Results 231 to 240 of about 33,351,014 (255)

Identification of a novel dual-targeting peptide inhibitor of SARS-CoV-2 RBD and NRP1 through structure-based virtual screening. [PDF]

Front Pharmacol
Yao N, Guan L, Feng L, Wang G, Wang Y, Niu MM, Yu M, Yin S.   +7 more
europepmc   +1 more source

Identification of New Human P2X7 Antagonists Using Ligand- and Structure-Based Virtual Screening. [PDF]

J Chem Inf Model
Zuanon M, Brancale A, Young MT.
europepmc   +1 more source

Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models. [PDF]

Eur J Med Chem
Upadhyay S, Talagayev V, Cho S, Wolber G, Gabr M.   +4 more
europepmc   +1 more source

Large-Scale Structure-Based Virtual Screening Identifies Diverse K _Na 1.1 (KCNT1) Potassium Channel Inhibitors

Caseley EA, Simmons KJ, Cole BA, Flynn AJ, Muench SP, Lippiat JD.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella R Korn, Karen Maria Emmons, Callie Walsh-Bailey   +2 more
exaly  

Time to add screening for financial hardship as a quality measure?

Ca-A Cancer Journal for Clinicians, 2021
Ya-Chen Tina Shih, Cathy J Bradley, Syed Yousuf Zafar   +2 more
exaly  

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Stacey A Fedewa, Richard C Wender, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2013†

Ca-A Cancer Journal for Clinicians, 2013
Robert A Smith, Otis Brawley, Durado Brooks   +2 more
exaly  

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Stacey A Fedewa, Richard C Wender, Robert A Smith   +2 more
exaly